
    
      A change in manufacturing site of lesinurad tablets has been implemented. This study is
      intended to evaluate the clinical comparability of lesinurad tablets manufactured at the two
      different sites by assessing relevant clinical Pharmacokinetics (PK) parameters.
    
  